AF-18748

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameAF-18748
Drug Alias NameAF-18748
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterleukin-5 receptors inhibitors
TargetsInterleukin-5 receptors
Therapy Area/IndicationsInflammationAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAffymax Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsInflammationAsthma

Other Information

ATC CodeN/A
Related LinksN/A